We honor 100 of the leading innovators in pathology and laboratory medicine by celebrating their success at the cutting edge of the field.
Flow cytometric immunophenotyping can speed up and standardize the diagnosis of leukemia and non-Hodgkin lymphoma
Automated IHC staining has limited capacity for heat-induced epitope retrieval – but a move to hybrid power lifts that barrier.
A new laser technique uses vibrations to listen to the metabolic activity of cancer cells, shedding light (and sound) on intratumoral heterogeneity.
David R. Hout
Triple-negative breast cancer is not a single entity, and understanding each patient’s molecular subtype can influence treatment and outcomes
Pancreatic cancer is associated with poor patient outcomes; could a new blood test improve screening accuracy for those at risk?
D-serine has shown potential as a biomarker for the prediction of kidney function and the detection of chronic kidney disease
Different glycosylation patterns in patients with idiopathic REM sleep behavior disorder could predict the future onset of neurodegenerative disease
A Jagged protein directly linked to cancer metastasis could be targeted to assess the aggressiveness of tumors and prevent their rapid spread
Liquid biopsy has shown promise as a rapid, minimally invasive way to profile tumors – but are commercially available tests accurate and consistent?
George Vasmatzis and John Cheville
Newly discovered genetic alterations could indicate whether treatment or active surveillance is the best option for low-risk prostate cancer patients
Send me the latest from The Pathologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.